MRSN

Mersana Therapeutics, Inc.

2.32 USD
-0.08 (-3.33%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Mersana Therapeutics, Inc. stock is down -26.58% since 30 days ago. The next earnings date is Aug 6, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 42.86% of the previous 6 May’s closed higher than April. In the last 9 Unusual Options Trades, there were 7 CALLs, 2 PUTs.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
01 Apr 17:56 16 Aug, 2024 5.00 CALL 684 181
01 Apr 18:55 16 Aug, 2024 5.00 CALL 286 181
01 Apr 19:19 16 Aug, 2024 5.00 CALL 571 181
12 Apr 13:46 16 Aug, 2024 5.00 CALL 411 3288
12 Apr 13:56 16 Aug, 2024 5.00 CALL 606 3288
18 Apr 15:10 17 Jan, 2025 3.00 PUT 270 6
18 Apr 15:11 17 Jan, 2025 2.50 PUT 409 15
26 Apr 15:29 15 Nov, 2024 5.00 CALL 525 539
09 May 14:33 16 Aug, 2024 5.00 CALL 2321 6772

About Mersana Therapeutics, Inc.

Mersana Therapeutics, Inc. develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for ovarian cancer and NSCLC adenocarcinoma.